A study on safety and efficacy of Deferasirox, an oral iron chelator in the treatment of transfusion haemosiderosis in children with β-Thalassemia Major in a tertiary care rural hospital
Journal Title: Journal of Medical Science And clinical Research - Year 2018, Vol 6, Issue 8
Abstract
Background: β-Thalassemia major is a hereditary hemolytic anaemia (and the commonest transfusion dependent anaemia) which continues to be a major cause of morbidity and mortality in developing countries like India. Deferasirox is a tridentate, once-daily, oral iron chelator that is widely used in the management of patients with transfusion haemosiderosis. Chelation therapy is usually started after 10-20 transfusions or when serum ferritin level reaches 1000 μg/L [Deferasirox has demonstrated consistent dose-dependent efficacy, producing sustained reductions in serum ferritin 6]. Aims and objective Aim: To study the safety and efficacy of Deferasirox in transfusion haemosiderosis in children with βThalassemia. Objectives 1. To assess the serum ferritin levels in multi-transfused β-Thalassemia patients who are on treatment with Deferasirox. 2. To study the efficacy of Deferasirox in patients admitted with transfusion haemosiderosis in β-Thalassemia. 3. To estimate iron overload in the patients admitted with transfusion haemosiderosis in β-Thalassemia. 4. To study the adverse effect profile andfinal outcome of administration of Deferasirox in patients with transfusion haemosiderosis in β-Thalassemia. Study Period: 6 months (After the approval from IEC- RMC) Sample Size: 100Results and Observation there was adecrease in serum ferritin from 4049.87ng/ml to 3647.4ng/ml this was a significant change with a p value 0f 0.0001. Furthermore, a significant negative correlation was observed between the mean dose of deferasirox prescribed and the mean serum ferritin levels. %). Diarrhoea was reported as the most common) in our study it was found that the mean change in the serum creatinine values increased from 0.475 to0.487(table7) in our study this change was not significant(table6)the findings for sodium and serum potassium were not considered significant (table 7 and 8) in our study .awareness among prescribers about ADRs of deferasirox and frequent monitoring of serum ferritin and serum iron levels as a guide to determine its dose is required to improve tolerability of this important and necessary drug.further multi-centered studies with more sample size are needed.
Authors and Affiliations
Dr Sanjay Shukla
Keywords
Related Articles
- EP ID EP489682
- DOI -
- Views 62
- Downloads 0
Laparoscopic Myomectomy—Complications and Conversion
Objectives: To evaluate the conversion rate and complications of laparoscopic myomectomy Material and Methods: It was a retrospective study of 43 cases of laparoscopic myomectomy performed over a period 28 months from De...
Prevalence of Diabetic Macular Edema in association with Severity of Diabetic Retinopathy
Introduction: Diabetic eye disease is a leading cause of vision loss in persons aged 20 to 74 years.1Diabetic retinopathy is the most common microvascular complication of diabetes 2 , and can be broadly divided into two...
Abruptio placenta: A Retrospective Study on Aetiological Factors and Maternal Outcomes
Background: Abruptio placenta denotes separation of a normally implanted placenta after 20 weeks of gestation. This is a uniquely dangerous condition to both the mother and the foetus because of its potentially serious p...
A study on safety and efficacy of Deferasirox, an oral iron chelator in the treatment of transfusion haemosiderosis in children with β-Thalassemia Major in a tertiary care rural hospital
Background: β-Thalassemia major is a hereditary hemolytic anaemia (and the commonest transfusion dependent anaemia) which continues to be a major cause of morbidity and mortality in developing countries like India. Defer...
Role of Uterine Packing in Control of Postpartum Haemorrhage in Modern Obstetrics
Background: Postpartum haemorrhage is the leading cause of maternal mortality in most low income countries. One of the earliest methods of achieving a tamponade effect on uterus to control PPH was by uterine packing. The...